IMMUNOVANT, INC. (IMVT) Capital expenditures 2019–2026
IMMUNOVANT, INC. (IMVT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$8,000FY2026 · since FY2019: $52,000 → $8,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $8,000 | -98.9% |
| FY2025 | $759,000 | +110.8% |
| FY2024 | $360,000 | +82.7% |
| FY2023 | $197,000 | -22.4% |
| FY2022 | $254,000 | +21.0% |
| FY2021 | $210,000 | +577.4% |
| FY2020 | $31,000 | -40.4% |
| FY2019 | $52,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice